S. E. Gibson et al. / Tetrahedron: Asymmetry 15 (2004) 465–473
471
i-PrOH, 98:2, 0.6 mL/min, 330 nm); (S)-enantiomer
tR ¼ 13:5 min (minor); (R)-enantiomer tR ¼ 18:0 min
CCrHCCrHPi-Pr2], 5.74 (1H, dd, J 7.3, 4.0, CHPPh2),
7.25–7.31 (3H, m, CarH), 7.41–7.47 (5H, m, CarH), 7.91–
7.96 (2H, m, CarH); dP{1H} (146 MHz, CDCl3) 0.3 (d, J
16.2, CHPPh2), 0.6 [d, J 16.2, CCrP(i-Pr2)]; m=z (EI, %)
586 (Mþ)CO, 2), 558 (M)2CO, 4), 530 (M)3CO, 100),
293 [M)Cr(CO)3) PPh2, 52]; HRMS (ESI) found
637.1690, C33H40CrO4 P2Na requires 637.1704.
24
D
(major): 97% ee; ½a ¼ þ133:4 (c 0.5, CH2Cl2); mmax
(CH2Cl2), cmꢀ1 1960s (CBO), 1882s (CBO). dH
(360 MHz, CDCl3) 1.08 (3H, t, J 7.2, CH3CH2), 1.16
[9H, s, (CH3)3C], 3.43–3.42(1H, m, CH 3CHH), 3.90
(1H, m, CH3CHH), 5.07 (2H, m, CHPPh2 and CCrH),
5.07 (1H, dd, J 8.0, 1.6, CCrH), 5.19 (1H, dd, J 8.6, 1.6,
CCrH), 5.28 (1H, d, J 6.9, CCrH), 7.18–7.31 (8H, m,
CarH), 7.45–7.50 (2H, t, J 7.4 CarH); dP{1H} (146 MHz,
CDCl3) 11.4 (CPPh2); dC{1H} (90 MHz, CDCl3) 14.2
(CH3CH2) 29.8 [(CH3)3C], 32.8 [(CH3)3C], 53.9 (d, J 4.2,
OCH2), 64.6 (d, J 14.3, CHPPh2), 80.6 [CCr(t-Bu)CCrH],
88.4 [CCr(t-Bu)CCrH], 88.7 [d, J 3.6, CCrHCCrCH(PPh2)
OMe], 89.4 [d, J 4.0, CCrHCCrCH(PPh2)OMe], 108.5 [d,
J 16.5, CCrCH(PPh2)OMe], 122.9 [CCr(t-Bu)], 125.6
(CarH), 126.8 (d, J 16.5, CarH), 127.1 (CarH), 127.2 (d, J
6.6, CarH), 132.4 (Car), 132.9 (d, J 19.0, CarH), 133.2(d,
J 20.4, CarH), 133.6 (Car), 140.5 (Car), 144.2(C ar), 233.7
(Cr-CBO); m=z (%) 512(M þ,1), 428 (M)3CO, 100), 384
(MH)3CO)C2H5O, 38), 332[MH )Cr(CO3))C2H5O,
3], 191 [M)Cr(CO)3)PPh2, 57], 52(Cr, 12); HRMS
(ESI) found 533.1878, C27H39O4 CrP+Na requires
533.1888.
4.8. ())-(1pR,10R)-Tricarbonyl[1-dicyclohexylphosphine-
2-(1-diphenylphosphine-1-methoxymethyl)-5-tert-butyl-
benzene]chromium(0) ())-8c
Flash column chromatography (SiO2; hexane/dichloro-
methane, 10:0–7:3) of the crude compound gave a 54%
yield of the title complex ())-8c as a yellow solid; mp
121–122 ꢁC; enantiomeric excess was determined by
HPLC analysis (Chiralcel OD-H, n-hexane/i-PrOH,
99.8:0.2, 0.15 mL/min, 330 nm); (pRR) enantiomer
tR ¼ 40:2min (major); ( pSS) enantiomer tR ¼ 44:2min
24
(minor): 97% ee; ½a ¼ ꢀ111:2 (c 0.5, CH2Cl2); mmax
D
(CH2Cl2), cmꢀ1 1962s (CBO), 1889s (CBO); dH
(360 MHz, CDCl3) 0.84 (2H, t, J ¼ 7:0 Hz, Cy), 1.17
[9H, s, (CH3)3C], 1.13–1.95 (17H, m, Cy), 3.09–3.14
(3H, m, Cy), 3.40 (3H, s, OCH3), 4.88 [1H, ddd, J 7.0,
3.0, 1.2, CCr(t-Bu)CCrHCCrH], 5.25 [1H, d, J 7.0,
CHPPh2], 5.58 (1H, s, CCr(t-Bu)CCrHCCrH), 5.63 [1H,
dd, J 7.5, 4.0 Hz, (t-Bu)CCrCHCCrPCy2], 7.16–7.22 (6H,
m, CarH), 7.35 (2H, dt, J 7.1, 1.7, CarH), 7.84–7.88 (2H,
m, CarH); dP{1H} (146 MHz, CDCl3) 0.8 (d, J 55.5 Hz,
CHPPh2), )6.9 (d, J 55.5 Hz, CCrPCy2); m=z (EI, %) 695
(2%, MHþ), 612(100, M )2CO)CH3+H), 369 [33,
M)PCy2)Cr(CO)3], 197 (9, PCy2); HRMS (ESI) found
695.2496 C39H48CrO4P2+H, requires 695.2506.
4.6. General procedure for the synthesis of complexes
8b–c (step iii)
Methyllithium (1.1n mmol) was added dropwise to a
stirred solution of tetramethylpiperidine (1.1n mmol) in
THF (10n mL) at )78 ꢁC. The solution was allowed to
reach room temperature and re-cooled to )78 ꢁC.
Diphosphine complex 7a–e (1n mmol) in THF (4n mL)
was added via a cannula and the resulting orange solu-
tion was stirred for 1 h, Chlorodialkyl or chlorodiaryl
phosphine (2n mmol) was added in one portion and
stirring was continued for a further 1 h at )78 ꢁC. The
reaction mixture was warmed to room temperature and
stirred for 1 h before methanol (0.5 mL) was added.
Removal of solvent in vacuo gave the crude product,
which was purified by flash column chromatography. All
the reactions were performed on 0.35–0.50 mmol scale.
4.9. ())(1pR,10Rb)-Tricarbonyl[1-di-3,5-dimethylphenyl-
phosphine-2-(10-diphenylphosphine-10-methoxymethyl)-5-
tert-butylbenzene]chromium(0) ())-8d
Flash column chromatography (SiO2; hexane/diethyl
ether, 10:0–95:5) of the crude compound gave a 83%
yield of title complex ())-8d as a crystalline yellow solid;
mp 98–100 ꢁC; enantiomeric excess was determined by
HPLC analysis (Chiralcel OD-H, n-hexane/i-PrOH,
99.6:0.4, 0.5 mL/min, 330 nm); (pSS)-enantiomer
4.7. ())-(1pR,10R)-Tricarbonyl[1-diisopropylphosphine-2-
(10-diphenylphosphine-10-methoxymethyl)-5-tert-butylben-
zene]chromium(0) ())-8b
tR ¼ 10:8 min (minor); (pRR)-enantiomer tR ¼ 2:6 min
24
(major): 97% ee; ½a ¼ ꢀ171 (c 0.5, CH2Cl2); mmax
D
Flash column chromatography (SiO2; hexane/dichloro-
methane, 10:0–7:3) of the crude compound gave a 56%
yield of the title complex ())-8b; enantiomeric excess was
determined by HPLC analysis (Chiralcel OD-H, n-hex-
ane/i-PrOH, 99.6:0.4, 0.3 mL/min, 330 nm); (pRR) enan-
(CH2Cl2), cmꢀ1 1962s (CBO), 1885s (CBO); dH
(360 MHz, CDCl3) 0.98, [9H, s, (CH3)3C], 2.20 (6H, s,
2 · PCarCH3), 2.25 (6H, s, 2 · PCarCH3) 3.02(3H, s,
OCH3), 4.75 [1H, t, J 1.1 (t-Bu)CCrCCrHCCrPAr2], 5.16
[1H, ddd, J 6.8, 3.6, 1.7, (t-Bu)CCrCCrHCCrH], 5.25 [1H,
dd, J 6.8, 1.1, CCr(t-Bu)CCrHCCrH], 5.47 (1H, dd, J 6.3,
4.3, CHPPh2), 6.82(1H, s, C arH), 6.98 (1H, s, CarH),
7.00 (1H, s, CarH), 7.02(1H, s, C arH), 7.31–7.47 (12H,
m, CarH); dP{1H} (146 MHz, CDCl3) )0.7 (d, J 10.3,
CHPPh2), )13.9 (d, J 10.3, CCrPAr2); m=z (EI, %) 738
(Mþ, 25), 710 (M)CO, 14), 682[MH )C(CH)3], 15), 654
(M)3CO, 100), 571 (M)Cr(CO)3)OCH3, 32), 377
[MH)P(C8H9)2)3CO)OCH3, 35]; HRMS (ESI) found
739.2186, C43H44CrO4P2+H requires 739.2194.
tiomer tR ¼ 18:0 min (major); (pSS) enantiomer tR ¼
24
20:3 min (minor): 97% ee; ½a ¼ ꢀ48:2 (c 0.5, CH2Cl2);
D
mmax (CH2Cl2), cmꢀ1 1962s (CBO), 1889s (CBO); dH
(360 MHz, CDCl3) 1.01–1.08 (6H, m, 2 · CHCH3), 1.18–
1.25 (12H, m, (CH3)3C and CHCH3), 1.34 (3H, dd, J
16.0, 7.0, CHCH3), 1.98–2.05 [m, 1H, CH(CH3)2], 2.12–
2.20 [1H, m, CH(CH3)2], 3.11 (3H, s, OCH3), 5.06 [1H,
ddd, J 6.5, 2.8, 1.6, CCr(t-Bu)CCrHCCrH], 5.33 [1H, d, J
6.5, CCr(t-Bu)CCrHCCrH], 5.59 [1H, s, CCr(t-Bu)